Daré Bioscience (NASDAQ:DARE) Upgraded to Buy at Brookline Capital Management tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Daré Bioscience (NASDAQ:DARE) Stock Rating Reaffirmed by HC Wainwright tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright Reiterates "Buy" Rating for Daré Bioscience (NASDAQ:DARE) dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
StockNews.com started coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the stock. Separately, Dawson James started coverage on shares of Tonix Pharmaceuticals in a research report on Wednesday, February 28th. They set a buy rating and […]
HC Wainwright reiterated their buy rating on shares of Daré Bioscience (NASDAQ:DARE – Free Report) in a report published on Wednesday morning, Benzinga reports. They currently have a $6.00 price objective on the biotechnology company’s stock. A number of other research analysts also recently issued reports on the stock. Dawson James downgraded shares of Daré […]